Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$33.58 - $41.2 $10,510 - $12,895
-313 Reduced 5.04%
5,896 $210,000
Q4 2022

Feb 13, 2023

SELL
$37.12 - $46.52 $17,112 - $21,445
-461 Reduced 6.91%
6,209 $234,000
Q3 2022

Nov 03, 2022

BUY
$36.54 - $48.66 $23,897 - $31,823
654 Added 10.87%
6,670 $295,000
Q2 2022

Aug 16, 2022

SELL
$31.71 - $43.0 $2,853 - $3,870
-90 Reduced 1.47%
6,016 $223,000
Q1 2022

May 16, 2022

BUY
$29.88 - $37.04 $182,447 - $226,166
6,106 New
6,106 $226,000
Q1 2021

May 14, 2021

SELL
$42.51 - $63.78 $233,252 - $349,960
-5,487 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$45.3 - $60.27 $19,886 - $26,458
439 Added 8.7%
5,487 $310,000
Q3 2020

Nov 12, 2020

SELL
$47.45 - $62.95 $17,698 - $23,480
-373 Reduced 6.88%
5,048 $240,000
Q2 2020

Aug 13, 2020

SELL
$46.85 - $61.05 $9,135 - $11,904
-195 Reduced 3.47%
5,421 $320,000
Q1 2020

May 13, 2020

SELL
$41.6 - $63.4 $268,112 - $408,613
-6,445 Reduced 53.44%
5,616 $266,000
Q4 2019

Feb 14, 2020

SELL
$53.85 - $65.27 $311,360 - $377,391
-5,782 Reduced 32.4%
12,061 $729,000
Q3 2019

Nov 08, 2019

SELL
$59.06 - $72.15 $251,890 - $307,719
-4,265 Reduced 19.29%
17,843 $1.07 Million
Q2 2019

Aug 07, 2019

SELL
$62.09 - $86.14 $80,592 - $111,809
-1,298 Reduced 5.55%
22,108 $1.42 Million
Q1 2019

Apr 30, 2019

SELL
$52.92 - $81.17 $102,347 - $156,982
-1,934 Reduced 7.63%
23,406 $1.9 Million
Q4 2018

Feb 12, 2019

SELL
$43.37 - $59.54 $30,142 - $41,380
-695 Reduced 2.67%
25,340 $1.37 Million
Q3 2018

Nov 13, 2018

SELL
$42.88 - $53.7 $7,332 - $9,182
-171 Reduced 0.65%
26,035 $1.34 Million
Q2 2018

Aug 14, 2018

BUY
$40.53 - $50.7 $157,134 - $196,563
3,877 Added 17.36%
26,206 $1.09 Million
Q1 2018

May 10, 2018

BUY
$44.08 - $55.05 $41,214 - $51,471
935 Added 4.37%
22,329 $984,000
Q4 2017

Feb 09, 2018

SELL
$50.3 - $64.39 $114,130 - $146,100
-2,269 Reduced 9.59%
21,394 $1.08 Million
Q3 2017

Nov 14, 2017

BUY
$45.56 - $59.57 $1.08 Million - $1.41 Million
23,663
23,663 $1.2 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.